Effervescent Tablet Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, India, Japan - Size and Forecast 2024-2028
| Published: Jan 2024 | Pages: 159 | SKU: IRTNTR74506 |
Effervescent Tablet Market Forecast 2024-2028
The global effervescent tablet market size is estimated to grow by USD 4.80 billion, at a CAGR of 8.36% between 2023 and 2028.
Effervescent tablets are a good alternative to regular tablets for people who have difficulty swallowing due to illness or aging. Older people may have difficulty swallowing tablets but need to take medications or supplements regularly. Swallowing Effervescent tablets is much simpler than swallowing a regular tablet. It is also a good way of swallowing medicine for people with sore throats or other medical conditions that make it difficult to swallow, making it a good alternative to regular tablets. Furthermore, effervescent pills provide immediate relief from any medical condition due to their uniform mixing in the water. It can be used to treat any medical condition based on its run time. Most importantly, it can heal disorders in a short period, as opposed to conventional medication, which takes a longer time to be digested by the body.
What will be the Size of the Market During the Forecast Period?
To learn more about this report, Download Report Sample
Market Segmentation by Distribution Channel, Type, and Geography Analysis
Distribution Channel Analysis
The market share growth by the hospital pharmacy segment will be significant during the forecast period. The increasing prevalence and diagnosis of diseases such as flue and gastrointestinal diseases and the increasing number of public and private specialty hospitals and clinics providing the tablets will influence the growth of the hospital pharmacy segment in this market.
Get a glance at the market contribution of various segments Download PDF Sample
The hospital pharmacy segment was the largest and was valued at USD 3.89 billion in 2018. Large hospitals and clinics are equipped with advanced medical infrastructure and procure high-quality medical products and consumables in bulk. Other factors that are positively influencing segmental growth include an increase in admissions of patients with symptoms such as headache, nausea, vomiting, photophobia, and phonophobia, which can increase the demand. As a result, the availability of efficient treatment and the increase in the number of patients visiting hospitals and clinics during the forecast period. Therefore, all such features will drive the growth of the hospital pharmacy segment in the market during the forecast period.
Type Analysis
A prescription drug is a medication that can only be prescribed to a patient under the written instructions of a licensed medical practitioner. Some examples of prescription drugs include blood pressure pills, cancer drugs, and powerful painkillers. A drug is considered a prescription drug because of several factors such as the safety of the product, the route of administration (e.g., injection), and the risk of drug abuse. The increasing prevalence of chronic diseases, rising number of patient visits to physicians and increasing healthcare expenditure by individuals are likely to boost the growth of the prescription segment in the market during the forecast period.
Regional Analysis
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional market growth and trends, and drivers that will shape the market during the forecast period. The market in North America is primarily driven by the demand for multivitamins and supplement tablets in the US, followed by Canada and Mexico. Consumers in developed countries in North America have a greater interest in a healthy diet due to the better awareness of the nutritional content of food products and the large-scale promotional activities undertaken by effervescent pills manufacturers, trade organizations, and medical institutions about the potential benefits of following a healthy diet. Further, the consumption of tablets in the region is expected to increase due to a significant rise in the demand for dietary and nutritional food products among millennials.
In addition, consumers in North America are more inclined toward organic and natural dietary products that supplement natural nutrients, and this preference has spurred the consumption of herbal and plant-based effervescent pills. Consumers in the region prefer to procure effervescent pills through online distribution channels, as this helps them compare products and their properties before making a decision. Internet and smartphone penetration is high in North America, which has increased the adoption of e-commerce for buying tablets. Such factors are expected to drive the regional market growth during market growth.
Key Market Players
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The market analysis and report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Alturix Ltd. - The company offers phosphate Sandoz.
- Bayer AG
- Bliss GVS Pharma Ltd.
- Bristol Myers Squibb Co.
- CHIESI Farmaceutici SpA
- GlaxoSmithKline Plc
- Herbalife International of America Inc.
- HERMES PHARMA GmbH
- Natur Produkt Zdrovit Sp Z O O
- Nestle SA
- Novartis AG
- Perrigo Co. Plc
- Pfizer Inc.
- Reckitt Benckiser Group Plc
- SciTech Specialities Pvt Ltd.
- Strava Healthcare Pvt. Ltd.
- S. G. Biopharm Pvt. Ltd.
- Swisse Wellness Pty Ltd.
- Vitabiotics Ltd.
- Vovantis Laboratories
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Market Dynamics
There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges.
Key Drivers
The rising prevalence of chronic diseases is a major driver. Effervescent pills are gaining popularity as they are convenient for physicians and patients alike. A sedentary lifestyle negatively affects the homeostasis of the body, making people susceptible to many illnesses, such as allergic conditions (cold, flu), chronic pain, and many more chronic diseases. Treatment of all these diseases has become critical, leading to hospitalization. Among chronic pain, migraine is the leading illness. According to the Migraine Research Foundation, migraines impact the health of more than 39 million US citizens every year.
Moreover, chronic respiratory diseases rank as 3rd most common cause of death. According to the National Center for Chronic Disease Prevention and Health Promotion, around 15.7 million Americans had chronic obstructive pulmonary disease (COPD) in 2021. These chronic illnesses require quick and convenient drug formulation. Individuals are choosing effervescent pills to treat chronic illnesses.
Significant Trends
The development of organic effervescent tablets is an emerging market trend. Most times effervescent pills are manufactured with ingredients synthetically derived that can interfere with tastes and fear of high sodium intake in some cases, which leads to a reduction in the adoption. However, the development of organic effervescent tablets might overcome the hurdle of traditional tablets.
For instance, effervescent pills prepared by the introduction of a significant amount of neem oil instead of silica and the use of potassium citrate offer the benefits of organic flavor and no risk of high sodium ingestion, which further increases the growth of the market during the forecast period.
Major Challenges
Side effects of effervescent tablets are a significant challenge hindering market growth. Tablets that quickly dissolve in water or another liquid and release carbon dioxide are known as effervescent pills. These tablets help quick therapeutic results for chronic illnesses such as migraine, headaches, hyperacidity, and allergies. However, effervescent tablets are prohibited in the majority of chronic diseases such as diabetes and asthma. Owing to the high sodium content in effervescent tablets might cause blood pressure issues in diabetic patients and muscle cramping after administration of effervescent pills might further worsen asthma in patients.
In addition, effervescent pills can cause further trouble if the patients are consuming opioid analgesics, antihistamines, and muscle relaxants. Tablets can cause trouble in breathing, dizziness, and nausea, which might disrupt patient compliance to the tablets, which might decline the growth of the market during the forecast period.
Key Market Customer Landscape
The market growth analysis report includes the adoption lifecycle of the market research and growth, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.
Customer Landscape
Market Analyst Overview
The market is witnessing significant growth in pharmaceuticals, catering to various administration routes such as oral, nasal, topical, and injectable. This expansion is fueled by an aging population, swallowing difficulties, and capsule compliance issues, particularly among children and the elderly. With a promising growth rate and increasing market value, market segments are diversifying, with extensive geographical coverage. Expert analysis indicates a dynamic market scenario, focusing on patient epidemiology, pipeline analysis, and pricing analysis within the regulatory framework.
Effervescent pills offer a convenient solution for chronic patients, promoting health awareness and supplementing disposable income. They encompass diverse formulations, including glucose tablets, probiotics, minerals, and dietary supplements, addressing a range of health issues like high blood pressure, cardiovascular disorders, and heart strokes, through innovative R&D activities and novel medications, while minimizing plastic usage and leveraging sodium bicarbonate for fizzing, bubbling, and rapid dissolution.
Segment Overview
The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2018.
- Distribution Channel Outlook
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
- Type Outlook
- Prescription
- Over the counter
- Region Outlook
- North America
- The U.S.
- Canada
- Europe
- The U.K.
- Germany
- France
- Rest of Europe
- Asia
- China
- India
- Rest of World (ROW)
- Brazil
- Argentina
- Australia
- North America
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
159 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Market forecasting period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 8.36% |
|
Market Growth 2024-2028 |
USD 4.80 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
7.84 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 41% |
|
Key countries |
US, Germany, UK, India, and Japan |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Alturix Ltd., Bayer AG, Bliss GVS Pharma Ltd., Bristol Myers Squibb Co., CHIESI Farmaceutici SpA, GlaxoSmithKline Plc, Herbalife International of America Inc., HERMES PHARMA GmbH, Natur Produkt Zdrovit Sp Z O O, Nestle SA, Novartis AG, Perrigo Co. Plc, Pfizer Inc., Reckitt Benckiser Group Plc, SciTech Specialities Pvt Ltd., Strava Healthcare Pvt. Ltd., S. G. Biopharm Pvt. Ltd., Swisse Wellness Pty Ltd., Vitabiotics Ltd., and Vovantis Laboratories |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
What are the Key Data Covered in this Market Research Report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the between 2024 and 2028
- Precise estimation of the size and its contribution of the market in focus to the parent market
- Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria
- Companies landscape comparing criticality of inputs and factors of differentiation
- Exclusive Matrix on companies position and classification
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the growth of companies
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global effervescent tablet market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global effervescent tablet market 2018 - 2022 ($ billion)
- 4.2 Distribution Channel Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ billion)
- 4.3 Type Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Type Segment 2018 - 2022 ($ billion)
- 4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
- 4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel
- 6.1 Market segments
- Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
- 6.2 Comparison by Distribution Channel
- Exhibit 32: Chart on Comparison by Distribution Channel
- Exhibit 33: Data Table on Comparison by Distribution Channel
- 6.3 Hospital pharmacy - Market size and forecast 2023-2028
- Exhibit 34: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
- Exhibit 35: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
- Exhibit 36: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
- 6.4 Retail pharmacy - Market size and forecast 2023-2028
- Exhibit 38: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
- Exhibit 39: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
- Exhibit 40: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
- 6.5 Online pharmacy - Market size and forecast 2023-2028
- Exhibit 42: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
- Exhibit 43: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
- Exhibit 44: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
- 6.6 Market opportunity by Distribution Channel
- Exhibit 46: Market opportunity by Distribution Channel ($ billion)
- Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)
7 Market Segmentation by Type
- 7.1 Market segments
- Exhibit 48: Chart on Type - Market share 2023-2028 (%)
- Exhibit 49: Data Table on Type - Market share 2023-2028 (%)
- 7.2 Comparison by Type
- Exhibit 50: Chart on Comparison by Type
- Exhibit 51: Data Table on Comparison by Type
- 7.3 Prescription - Market size and forecast 2023-2028
- Exhibit 52: Chart on Prescription - Market size and forecast 2023-2028 ($ billion)
- Exhibit 53: Data Table on Prescription - Market size and forecast 2023-2028 ($ billion)
- Exhibit 54: Chart on Prescription - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Prescription - Year-over-year growth 2023-2028 (%)
- 7.4 Over the counter - Market size and forecast 2023-2028
- Exhibit 56: Chart on Over the counter - Market size and forecast 2023-2028 ($ billion)
- Exhibit 57: Data Table on Over the counter - Market size and forecast 2023-2028 ($ billion)
- Exhibit 58: Chart on Over the counter - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Over the counter - Year-over-year growth 2023-2028 (%)
- 7.5 Market opportunity by Type
- Exhibit 60: Market opportunity by Type ($ billion)
- Exhibit 61: Data Table on Market opportunity by Type ($ billion)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 63: Chart on Market share by geography 2023-2028 (%)
- Exhibit 64: Data Table on Market share by geography 2023-2028 (%)
- 9.2 Geographic comparison
- Exhibit 65: Chart on Geographic comparison
- Exhibit 66: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 India - Market size and forecast 2023-2028
- Exhibit 87: Chart on India - Market size and forecast 2023-2028 ($ billion)
- Exhibit 88: Data Table on India - Market size and forecast 2023-2028 ($ billion)
- Exhibit 89: Chart on India - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on India - Year-over-year growth 2023-2028 (%)
- 9.9 Germany - Market size and forecast 2023-2028
- Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.10 Japan - Market size and forecast 2023-2028
- Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
- Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
- Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 9.11 UK - Market size and forecast 2023-2028
- Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity by geography
- Exhibit 103: Market opportunity by geography ($ billion)
- Exhibit 104: Data Tables on Market opportunity by geography ($ billion)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 105: Impact of drivers and challenges in 2023 and 2028
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 107: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 108: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 109: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 110: Matrix on vendor position and classification
- 12.3 Alturix Ltd.
- Exhibit 111: Alturix Ltd. - Overview
- Exhibit 112: Alturix Ltd. - Product / Service
- Exhibit 113: Alturix Ltd. - Key offerings
- 12.4 Bayer AG
- Exhibit 114: Bayer AG - Overview
- Exhibit 115: Bayer AG - Business segments
- Exhibit 116: Bayer AG - Key news
- Exhibit 117: Bayer AG - Key offerings
- Exhibit 118: Bayer AG - Segment focus
- 12.5 Bliss GVS Pharma Ltd.
- Exhibit 119: Bliss GVS Pharma Ltd. - Overview
- Exhibit 120: Bliss GVS Pharma Ltd. - Business segments
- Exhibit 121: Bliss GVS Pharma Ltd. - Key offerings
- Exhibit 122: Bliss GVS Pharma Ltd. - Segment focus
- 12.6 Bristol Myers Squibb Co.
- Exhibit 123: Bristol Myers Squibb Co. - Overview
- Exhibit 124: Bristol Myers Squibb Co. - Product / Service
- Exhibit 125: Bristol Myers Squibb Co. - Key news
- Exhibit 126: Bristol Myers Squibb Co. - Key offerings
- 12.7 CHIESI Farmaceutici SpA
- Exhibit 127: CHIESI Farmaceutici SpA - Overview
- Exhibit 128: CHIESI Farmaceutici SpA - Product / Service
- Exhibit 129: CHIESI Farmaceutici SpA - Key offerings
- 12.8 GlaxoSmithKline Plc
- Exhibit 130: GlaxoSmithKline Plc - Overview
- Exhibit 131: GlaxoSmithKline Plc - Business segments
- Exhibit 132: GlaxoSmithKline Plc - Key news
- Exhibit 133: GlaxoSmithKline Plc - Key offerings
- Exhibit 134: GlaxoSmithKline Plc - Segment focus
- 12.9 HERMES PHARMA GmbH
- Exhibit 135: HERMES PHARMA GmbH - Overview
- Exhibit 136: HERMES PHARMA GmbH - Product / Service
- Exhibit 137: HERMES PHARMA GmbH - Key offerings
- 12.10 Natur Produkt Zdrovit Sp Z O O
- Exhibit 138: Natur Produkt Zdrovit Sp Z O O - Overview
- Exhibit 139: Natur Produkt Zdrovit Sp Z O O - Product / Service
- Exhibit 140: Natur Produkt Zdrovit Sp Z O O - Key offerings
- 12.11 Nestle SA
- Exhibit 141: Nestle SA - Overview
- Exhibit 142: Nestle SA - Business segments
- Exhibit 143: Nestle SA - Key news
- Exhibit 144: Nestle SA - Key offerings
- Exhibit 145: Nestle SA - Segment focus
- 12.12 Novartis AG
- Exhibit 146: Novartis AG - Overview
- Exhibit 147: Novartis AG - Business segments
- Exhibit 148: Novartis AG - Key offerings
- Exhibit 149: Novartis AG - Segment focus
- 12.13 Perrigo Co. Plc
- Exhibit 150: Perrigo Co. Plc - Overview
- Exhibit 151: Perrigo Co. Plc - Business segments
- Exhibit 152: Perrigo Co. Plc - Key news
- Exhibit 153: Perrigo Co. Plc - Key offerings
- Exhibit 154: Perrigo Co. Plc - Segment focus
- 12.14 Pfizer Inc.
- Exhibit 155: Pfizer Inc. - Overview
- Exhibit 156: Pfizer Inc. - Product / Service
- Exhibit 157: Pfizer Inc. - Key news
- Exhibit 158: Pfizer Inc. - Key offerings
- 12.15 Reckitt Benckiser Group Plc
- Exhibit 159: Reckitt Benckiser Group Plc - Overview
- Exhibit 160: Reckitt Benckiser Group Plc - Business segments
- Exhibit 161: Reckitt Benckiser Group Plc - Key offerings
- Exhibit 162: Reckitt Benckiser Group Plc - Segment focus
- 12.16 S. G. Biopharm Pvt. Ltd.
- Exhibit 163: S. G. Biopharm Pvt. Ltd. - Overview
- Exhibit 164: S. G. Biopharm Pvt. Ltd. - Product / Service
- Exhibit 165: S. G. Biopharm Pvt. Ltd. - Key offerings
- 12.17 SciTech Specialities Pvt Ltd.
- Exhibit 166: SciTech Specialities Pvt Ltd. - Overview
- Exhibit 167: SciTech Specialities Pvt Ltd. - Product / Service
- Exhibit 168: SciTech Specialities Pvt Ltd. - Key offerings
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 169: Inclusions checklist
- Exhibit 170: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 171: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 172: Research methodology
- Exhibit 173: Validation techniques employed for market sizing
- Exhibit 174: Information sources
- 13.5 List of abbreviations
- Exhibit 175: List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
PURCHASE FULL REPORT OF
effervescent tablet market market
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
- Off-the-shelf research reports
- Reports can be tailored to meet the customer's needs
- Trusted by more than 100 fortune 500 organizations
- Information about the market's key drivers, trends, and challenges
- Parent market analysis
- Every week, 50,000 people visit our subscription platform
- Detailed vendors report with competitive landscape
- Covid-19 impact and recovery analysis
- Data on revenue-generating market segments
- Details on the market shares of various regions
- Five-force market analysis